Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 143,912
  • Shares Outstanding, K 37,477
  • Annual Sales, $ 128,870 K
  • Annual Income, $ -38,720 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.88
  • Price/Sales 1.10
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 188.88% (-11.70%)
  • Historical Volatility 121.96%
  • IV Percentile 97%
  • IV Rank 43.13%
  • IV High 385.59% on 03/19/26
  • IV Low 39.69% on 09/08/25
  • Expected Move (DTE 11) 1.11 (27.15%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 14
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 2,018
  • Open Int (30-Day) 2,004
  • Expected Range 2.97 to 5.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.25
  • Number of Estimates 2
  • High Estimate $-0.24
  • Low Estimate $-0.27
  • Prior Year $-0.19
  • Growth Rate Est. (year over year) -31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.63 +12.28%
on 03/31/26
7.16 -43.20%
on 03/10/26
-2.89 (-41.52%)
since 03/06/26
3-Month
3.63 +12.28%
on 03/31/26
8.98 -54.68%
on 01/27/26
-3.84 (-48.55%)
since 01/06/26
52-Week
3.63 +12.28%
on 03/31/26
8.98 -54.68%
on 01/27/26
-1.22 (-23.06%)
since 04/04/25

Most Recent Stories

More News
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”),...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company

-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical: Q4 Earnings Snapshot

Lifecore Biomedical: Q4 Earnings Snapshot

LFCR : 4.07 (+5.99%)
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

-- Recorded  Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of $75.5 Million -- -- Multiple New Programs Signed in Fourth Quarter 2025 Including Two Commercial Site...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum

CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”),...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026

CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”),...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen ™ , its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture...

LFCR : 4.07 (+5.99%)
Lifecore Biomedical to Participate at DCAT Week 2026

CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”),...

LFCR : 4.07 (+5.99%)
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

LFCR : 4.07 (+5.99%)

Business Summary

Lifecore Biomedical Inc. is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. Lifecore Biomedical Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 4.58
2nd Resistance Point 4.36
1st Resistance Point 4.22
Last Price 4.07
1st Support Level 3.86
2nd Support Level 3.64
3rd Support Level 3.50

See More

52-Week High 8.98
Fibonacci 61.8% 6.93
Fibonacci 50% 6.30
Fibonacci 38.2% 5.67
Last Price 4.07
52-Week Low 3.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.